Skip to main content
ABVC BIOPHARMA, INC. logo

ABVC BIOPHARMA, INC. — Investor Relations & Filings

Ticker · ABVC ISIN · US00091F1066 US Manufacturing
Open in API
Filings indexed 780 across all filing types
Latest filing 2019-05-08 Regulatory Filings
Country US United States of America
Listing US ABVC

About ABVC BIOPHARMA, INC.

https://abvcpharma.com/

ABVC BioPharma, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes drugs and medical devices to address unmet medical needs. The company focuses on advancing a pipeline of botanical, plant-based pharmaceuticals and medical technologies sourced from research institutions. Its therapeutic areas of focus include oncology, ophthalmology, and central nervous system disorders such as major depressive disorder (MDD) and adult attention-deficit/hyperactivity disorder (ADHD). Key products in development include Vitargus®, a biodegradable vitreous substitute for eye surgery, and botanical drug candidates for MDD and ADHD. Additionally, its subsidiary, BioKey, Inc., offers contract development and manufacturing services for nutritional and pharmaceutical products.

Recent filings

Filing Released Lang Actions
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated May 8, 2019, reporting a corporate action: a reverse stock split and amendment to the articles of incorporation. It includes details about the board's unanimous written consent, the filing of the certificate of amendment, and the effective date of the reverse split. The document is short (4114 characters) and primarily serves as a regulatory announcement of a corporate event rather than a detailed financial report or management discussion. It does not contain financial statements or detailed financial analysis. The content fits the category of a Regulatory Filing (RNS) as it is a general regulatory announcement about a corporate action and amendment filing with the SEC, not a full report like an Annual Report or Interim Report, nor a capital/financing update since it is about a stock split and amendment rather than new financing. Therefore, the best classification is Regulatory Filings (RNS).
2019-05-08 English
ANNUAL REPORT
Annual Report FY 2018
2019-04-15 English
NOTIFICATION OF LATE FILING
Regulatory Filings Classification · 100% confidence The document is a Form 12b-25, which is a Notification of Late Filing submitted to the SEC. It specifically states that the registrant, American BriVision (Holding) Corporation, was unable to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2018 on time and requests additional time to file it. The document does not contain the actual 10-K report or financial data but is a notification about the delay in filing the 10-K. According to the rules, such a notification is classified as a Regulatory Filing (RNS) because it is a compliance document related to the filing process and not the report itself.
2019-04-02 English
Regulatory Filings 2019
Regulatory Filings Classification · 60% confidence The provided document text appears to be encoded or encrypted and does not contain any readable content, keywords, regulatory headers, or fiscal period dates that would allow identification of a specific filing type. There is no indication of report titles, financial data, or announcements. Given the lack of discernible information, the document cannot be classified into any specific category and defaults to the fallback category for miscellaneous or unclassifiable filings, which is Regulatory Filings (RNS). The confidence is moderate due to the inability to analyze content but the clear absence of identifiable features.
2019-02-25 English
CURRENT REPORT
Regulatory Filings Classification · 95% confidence The document is a Form 8-K Current Report filed with the SEC, dated February 14, 2019, reporting the completion of acquisition transactions (mergers) involving American BriVision (Holding) Corporation and its subsidiaries BioLite and BioKey. The content includes detailed descriptions of the merger agreements, closing dates, share issuance related to the mergers, and business descriptions of the acquired entities. The document is a regulatory filing that reports a significant corporate event (completion of acquisition) but does not contain financial statements or earnings data. It is not an annual or quarterly report, nor an earnings release, nor a proxy or voting result. The primary focus is on merger completion and related corporate actions. According to the filing definitions, this fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit more specific categories like M&A Activity (TAR) or Merger & Acquisition (MA) forms, since it is a Form 8-K reporting the event rather than a merger proxy or tender offer filing. Confidence is high given the clear identification of the form and content.
2019-02-14 English
AMENDMENT NO. 1 TO FORM S-1
Capital/Financing Update Classification · 95% confidence The document is an Amendment No. 1 to Form S-1 Registration Statement filed with the SEC, which is a registration statement for a securities offering under the Securities Act of 1933. It includes detailed information about the securities being registered, the offering terms, underwriting arrangements, and other disclosures typical of a registration statement. This type of filing is related to capital raising activities and financing. It is not an annual report, earnings release, or any other type of financial report. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length is substantial (15,000 characters), and it contains the full registration statement amendment, not just an announcement or certification, so it is not RPA or RNS. Confidence is high given the clear identification as an S-1 amendment registration statement for a securities offering.
2019-02-14 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.